ストックスクリーナーアプリを入手
25.31
3.69%
0.90
プレマーケット:
24.81
-0.50
-1.98%
前日終値:
$24.41
開ける：
$24.42
24時間の取引高:
126.09K
Relative Volume:
0.88
時価総額：
$852.88M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.85%
1か月 パフォーマンス:
-2.99%
6か月 パフォーマンス:
+34.84%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$24.42
$26.15
1週間の範囲:
$23.63
$26.54
52週間の値動き範囲:
$14.35
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
AVBP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
25.31 | 852.88M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-22 | 開始されました | Oppenheimer | Outperform |
| 2024-04-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-02-20 | 開始されました | Citigroup | Buy |
| 2024-02-20 | 開始されました | Goldman | Buy |
| 2024-02-20 | 開始されました | Jefferies | Buy |
Arrivent Biopharma Inc (AVBP) 最新ニュース
Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers - The Manila Times
Lepu Biopharma Co., Ltd. Enters into an Exclusive Licensing Agreement with Arrivent Biopharma, Inc - Marketscreener.com
Lepu Biopharma Grants Exclusive License for Novel ADC MRG007 to ArriVent - TipRanks
ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers - The Manila Times
ArriVent BioPharma Secures Global Rights to Promising Cancer Drug MRG007 in $1.2B Deal - StockTitan
(AVBP) Investment Analysis - Stock Traders Daily
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Up 13.1% in December - MarketBeat
ArriVent BioPharma (NASDAQ:AVBP) Shares Gap DownWhat's Next? - MarketBeat
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Barclays PLC Has $976,000 Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline - BioWorld Online
Jane Street Group LLC Has $250,000 Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
We're Not Very Worried About ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Rate - Simply Wall St
ArriVent BioPharma (NASDAQ:AVBP) Trading Down 5%Should You Sell? - MarketBeat
Geode Capital Management LLC Increases Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Barclays PLC Increases Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Stock Position Increased by Geode Capital Management LLC - MarketBeat
Barclays PLC Buys 38,132 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat
(AVBP) Proactive Strategies - Stock Traders Daily
State Street Corp Acquires 323,186 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Stake Lifted by State Street Corp - Defense World
(AVBP) Pivots Trading Plans and Risk Controls - Stock Traders Daily
The Manufacturers Life Insurance Company Purchases Shares of 10,234 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Up 6.1% in November - MarketBeat
Charles Schwab Investment Management Inc. Buys 122,641 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
BNP Paribas Financial Markets Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Fmr LLC Purchases 169,514 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat
Suvretta Capital Management, LLC Acquires Additional Shares in A - GuruFocus.com
Short Interest in ArriVent BioPharma, Inc. (NASDAQ:AVBP) Decreases By 11.9% - MarketBeat
Suvretta Capital Management LLC Purchases 132,459 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat
(AVBP) Trading Report - Stock Traders Daily
ArriVent BioPharma Reports Advancements and Q3 2024 Financial Results - MSN
Where are the Opportunities in (AVBP) - Stock Traders Daily
ArriVent Biopharma Inc (AVBP) Stock Price & Chart | Trade Now - Capital.com
ArriVent BioPharma (NASDAQ:AVBP) Receives Buy Rating from HC Wainwright - MarketBeat
Medicus Pharma completes IPO, becomes second local life sciences company to go public in 2024 - The Business Journals
ArriVent BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ArriVent BioPharma Reports Third Quarter 2024 Financial Results - The Bakersfield Californian
ArriVent Reports $282.9M Cash Position, Firmonertinib Shows Promise in NSCLC Trial | AVBP Stock News - StockTitan
FMR LLC's Strategic Acquisition of ArriVent BioPharma Inc Shares - GuruFocus.com
(AVBP) On The My Stocks Page - Stock Traders Daily
Discover the 3 Best-Performing Biotech IPO Stocks of 2024 - MSN
AlphaCentric Advisors LLC Cuts Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - MarketBeat
Long Term Trading Analysis for (AVBP) - Stock Traders Daily
ArriVent BioPharma Reports Strong Second Quarter and Highlights Progress - MSN
ArriVent BioPharma (NASDAQ:AVBP) Reaches New 12-Month HighShould You Buy? - MarketBeat
ArriVent To Present FURTHER Data At The 2024 World Conference On Lung Cancer - RTTNews
When the Price of (AVBP) Talks, People Listen - Stock Traders Daily
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Up 80.1% in September - MarketBeat
Octagon Capital Advisors LP Increases Stake in ArriVent BioPharma Inc - Yahoo Finance
Arrivent Biopharma Inc (AVBP) 財務データ
Arrivent Biopharma Inc (AVBP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Arrivent Biopharma Inc (AVBP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| HILLHOUSE INVESTMENT MANAGEMEN | 10% Owner |
Jan 30 '24 |
Buy |
18.00 |
555,555 |
9,999,990 |
4,484,672 |
| ORBIMED ADVISORS LLC | Director |
Jan 30 '24 |
Buy |
18.00 |
444,444 |
7,999,992 |
1,513,664 |
| GORDON CARL L | Director |
Jan 30 '24 |
Buy |
18.00 |
444,444 |
7,999,992 |
1,513,664 |
| HEALY JAMES | Director |
Jan 30 '24 |
Buy |
18.00 |
444,444 |
7,999,992 |
1,696,752 |
4.81%
大文字化:
|
ボリューム (24 時間):